space, we will enable the rapid development of both drugs and biomarkers. We have the capability to fully automate assay mixing and get results in less than 30 minutes, opening the door to rapid diagnostic applications, where we can make personalized medicine through cancer genotyping routine. Our integrated microfluidic technology brings digital PCR to the field in a compact, portable form factor, enabling our users to bring a molecular biology laboratory anywhere.